Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)

Status Recruiting

Clinical Trial Summary

Eligible eyes are randomly assigned into two groups. Group A receive Fasudil eye drops (concentration 0.5 percent) twice daily. Group B, receive artificial tears drop with the same frequency. Retinal specialists who are expert in Retinopathy Of Prematurity field will perform fundus examination regularly. The examiners are blind. The progression of normal retinal vascularization and need to treatment will be documented and compared between the two study groups. The topical eye drops are used until the retinal vascularization are complete (45 week after LMP) or the patient needs to be treated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04191954
Study type	Interventional
Source	Shahid Beheshti University of Medical Sciences
Contact	Alireza Ramezani, MD
Phone	009822591616
Email	labbafi@hotmail.com
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	June 2, 2019
Completion date	September 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05043077` - Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening	Phase 4
Completed	`NCT04838665` - Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study	Phase 4
Completed	`NCT04408807` - Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided	N/A
Recruiting	`NCT03083431` - Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity	Phase 2
Enrolling by invitation	`NCT04985448` - Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
Recruiting	`NCT02090322` - Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1	N/A
Completed	`NCT00872664` - Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids	N/A
Unknown status	`NCT00254176` - Cysteine Supplementation in Critically Ill Neonates	Phase 2/Phase 3
Completed	`NCT06452524` - Prematurity and Ophthalmological Changes
Completed	`NCT04101721` - Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity	Phase 3
Enrolling by invitation	`NCT02050971` - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates	Phase 1
Terminated	`NCT01335113` - A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Active, not recruiting	`NCT00027222` - The Early Treatment for Retinopathy of Prematurity Study (ETROP)	Phase 2/Phase 3
Recruiting	`NCT06109285` - Validation of i-ROP DL to Detect More Than Mild ROP	N/A
Completed	`NCT01861470` - REDEXAM - Reducing Painful Eye Examinations in Preterm Infants	N/A
Completed	`NCT02014454` - Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature	Phase 2
Terminated	`NCT00634972` - Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity	Phase 4
Completed	`NCT05701124` - Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity	Phase 3
Completed	`NCT04092127` - Pain of Premature Babies and RetCam (DOLICAM)
Completed	`NCT04621136` - PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity	Phase 1/Phase 2